Carson Wealth (CWM LLC)’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1	Closed	–	–	3460
2018 Q4	$0	Hold	1	–	–	﹤0.01%	2337
2018 Q3	$0	Hold	1	–	–	﹤0.01%	2073
2018 Q2	$0	Hold	1	–	–	﹤0.01%	1820
2018 Q1	$0	Buy	+1	New	+$16	﹤0.01%	1601

Other funds holding EMMA

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EMMA Position: Q1 2019 in Review

Carson Wealth (CWM LLC) sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q1 2019, closing a stake of 1 share.

Carson Wealth (CWM LLC) first reported a position in EMMA in Q1 2018 and held it in 4 quarters. The position peaked at $0 in Q4 2018. 7 funds tracked by Wall St. Rank hold EMMA as of Q1 2019.

Carson Wealth (CWM LLC) reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 1 Emmaus Life Sciences, Inc. Common Stock share in Q1 2019.
Carson Wealth (CWM LLC) first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q1 2018 and held it in 4 quarters.
Carson Wealth (CWM LLC)'s Emmaus Life Sciences, Inc. Common Stock position peaked at $0 in Q4 2018.
7 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q1 2019.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2019, filed 22 Apr 2019.